Image Credit: Clinical Trial Arena Announcement The Thermo Fisher Scientific’s PPD™ clinical research business holder and the global leader in delivering science has introduced its innovative clinical trial carbon calculator. The innovative clinical trial carbon calculator is enginee...
Image Credit: CCO Announcement Cairn Surgical Inc., a leading creative medical technology company, actively participates in making breast cancer surgery more accurate, informed that the multicentre study publicly published in the November issue of the Annals of Surgical Oncology elaborated...
Image Credit: Contract Pharma Announcement Ventus Therapeutics, a leading clinical-level biopharmaceutical company upgrading two phase 2 small-molecule programs for inflammatory, neurological and immunological disorders, has entered a long-term partnership with Genentech. A Genentech is a ...
Image Credit: Quantzig Announcement Since AI has entered the global market across all sectors, it has initially been met with hesitation among biopharma companies. Today, AI is transforming the traditional methods and shifting the nature of leadership at every stage in biopharma. The execu...
Announcement The Aletheia Capital Endeavours (ACE), a leading firm, has introduced the repIntel solution. It’s an accurate field-smart platform engineered to fill a part of the gap in healthcare’s failure in lifesaving, precious therapies that should’ve reached the patient...
Image Credit: Xortx Announcement XORTX Therapeutics Inc., a leading late-stage clinical pharmaceutical company, aims to establish creative therapies for the treatment of progressive kidney disease and gout conditions, has signed a binding term sheet for the acquisition of Vectus Biosystems...
Image Credit: The Manila Times Announcement Corvus Pharmaceuticals Inc., a leading clinical-level biopharmaceutical company, will be showcasing the interim data from the comprehensive phase 1b/2 clinical trial of ciforadenant for metastatic renal cell cancer (RCC) patients today in the ora...
Image Credit: ChemXplore Announcement Novo Nordisk received approval from the US Food and Drug Administration (FDA) for Rybelsus. The Rybelsus® is the first ever GLP-1 medication for alleviating the risk of crucial adverse cardiovascular events (MACE) like heart attack, stroke or cardi...
Image Credit: americanbuilt. app Announcement AB Science, a leading French pharmaceutical company, aims to establish novel drugs to offer unmet medical needs for conditions like neurology, inflammation, and oncology has delivered initial phase 1 data for the merger of AB8939 with relapsed ...
Image Credit: Pharmafile Announcement Genentech, a valuable member of the Roche Group, launched the company’s first-ever direct-to-patient (DTP) program. The program strongly contributes to President Trump’s goal to deliver affordable medicines to American patients, specificall...
